Category Archives: Enterprise

NSF Idea Machine due Oct. 26. $26,000 for the best idea

How to get involved:

1.     Use our promotional toolkit to help promote the Idea Machine to your network by sharing through social media and email

2.     Submit an entry yourself or on behalf of your organization

3.     Call me or reply to this email my direct line is in my signature. We can discuss ways your organization can help promote the 2026 Idea Machine to your network.

Deadline: October 26, 2018, 5pm EST.

Prize Purse

1.     Grand prize: Each final winning entry will receive a cash prize of $26,000 and its authors (individuals or teams) will be invited to a recognition event in the Washington, D.C. area.

2.     Each author (individual or team member) of the entries selected by the Blue-Ribbon Panel for virtual interviews (approximately 12) will receive a cash prize of $1,000.

3.     All authors (individual and teams) of each of the entries invited to submit video pitches (approximately 30) will receive thank-you letters from NSF leadership.

4.     The authors of the top, approximately 100 entries will receive public recognition by having their Ideas posted on the Idea Machine website.

What is a “Big Idea”?

Copyright © 2018 Skild, All rights reserved.

Mi-TRAC RFP: Due September 24

Dear Colleagues,  Below is an opportunity for funding to help translate your research and student projects from the idea/preliminary prototype stage to a deployable prototype for commercialization.  I’d be happy to discuss my own experiences in this area and provide guidance on any proposals.   Best – Adrienne


We’re excited to kick off the third year of FFMI’s MTRAC for Life Sciences Innovation Hub. With the renewal of funding from the Michigan Economic Development Corporation (MEDC), FFMI’s biomedical research innovation and commercialization program is continuing to grow and expand across the state of Michigan.

The first two years of this translational research program have been a resounding success, with funded projects from U-M, as well as many of our statewide partners such as Henry Ford Health System, Michigan State University, Michigan Tech, Spectrum Health, Wayne State University, Western Michigan University, Grand Valley State University, and the Beaumont Health System. The FFMI MTRAC for Life Sciences Innovation Hub program, in partnership with the U-M Office of Tech Transfer, has an operating budget in excess of $4 million, with half of the funds coming from MEDC and half from partnering organizations with projects chosen for funding.

Innovators from all units at the University of Michigan, other institutions of higher education, non-profit research centers, and hospital systems across Michigan are eligible to submit biomedical projects for funding consideration. The program offers early-stage funding opportunities throughMi-Kickstart, and Mi-TRAC is our funding program for mid-stage commercialization projects.


We have posted the RFP for Mi-TRAC in Competition Space, with proposals due Monday, Sept. 24. Each proposal will be evaluated on the basis of scientific merit, potential health care impact and significance, the potential for commercialization, and likelihood of obtaining further support. Earlier this year, 11 different proposals were awarded in the four targeted markets of devices, diagnostics, therapeutics, and healthcare IT, and we’re looking forward to growing that number. The RFP for the next Mi-Kickstart will be announced later in the fall.

Complete instructions for proposal submission can be found at the Mi-TRAC website, and
I encourage you to contact Brad Martin, Sr. Director of Commercialization Programs, for a
pre-proposal consultation.

We’re excited to continue working closely with our MEDC partner to broaden the scope of this unique innovation pipeline program and expand to more institutions across the state. The FFMI team looks forward to working with you on projects that are paving the way for positive impact for patients and their families.
Best regards,

Connie Chang, M.B.A.
Interim Executive Director
Fast Forward Medical Innovation